Validation of the simplified Chinese version of EORTC QLQ-C30 from the measurements of five types of inpatients with cancer. Wan C(1), Meng Q, Yang Z, Tu X, Feng C, Tang X, Zhang C. Author information: (1)School of Public Health, Kunming Medical University, Kunming, Yunnan, China. wanchh@hotmail.com

The EORTC has developed a myeloma module referred to as QLQ-MY20, to be administered alongside the core QLQ-C30 [11]. The module has been validated

The MeSH-terms (Medical SubHeadings) used were: “Quality of Life” combined with “Colorectal Neoplasms/psych-ology”, “Colorectal Neoplasms/therapy”, “Psychometrics/ Conclusion: This study provides preliminary evidence for the validity and reliability of the EORTC QLQ-C30 in English-speaking Singaporean cancer patients. The most commonly used QOL tool in oncology is the European Organization for Research and Treatment of Cancer QOL measure (EORTC QLQ-C30). The aim of VALIDATION STUDY FOR SPANISH PROSTATE CANCER PATIENTS. Juan Ignacio Arraras Validation studies for Spain of the QLQ-C30. (version 3.0) 3 with The EORTC has developed a myeloma module referred to as QLQ-MY20, to be administered alongside the core QLQ-C30 [11]. The module has been validated 12 Nov 2018 The EORTC QLQ-TC26 questionnaire module has been developed to supplement the EORTC QLQ-C30 in assessing TC-specific HRQOL in 25 Jan 2011 oncology, QoL, EORTC QLQ-C30, translation, validation, Indonesia linguistically validate the Indonesian version of the EORTC QLQ-C30 in Reliability and validity of the EORTC QLQ-C30 in palliative care cancer patients. Hubert Jocham , Theo Dassen , Guy Widdershoven , and Ruud Halfens.

Qlq-c30 validation

We employed the EORTC QLQ-C30 quality-of-life questionnaire to study 95 cancer patients and measured the agreement between (1) the patient's self-assessment and (2) an observer's rating of the patient's open-ended responses to the same questionnaire administered as an interview. Validation of the EORTC QLQ-C30 Summary Score in patients with hematological malignancies. , Background: The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) is a widely used questionnaire, which assesses 15 patients’ self-reported health domains, including physical and emotional Validation of the Korean version of the EORTC QLQ-C30. This study evaluated the Korean version of the EORTC QLQ-C30 (version 3.0) in terms of psychometric properties and its validation. One hundred and seventy patients completed three questionnaires EORTC QLQ-C30, the Beck depression inventory (BDI), and a brief pain inventory (BPI). 1997-04-01 · Validation of the EORTC QLQ-C30 443 The questionnaire used for the gynecological cancer pa- tients contained 73 additional items, some of which were inserted among the items of the EORTC QLQ-C30.

3 EORTC QLQ-C30 EORTC (European Organisation for Research and 21 MPN-SAF At diagnosis n=179 Validation Trial n=402 Swedish cohort n=114

It can be concluded that the QLQ-H&N35, in conjunction with the QLQ-C30, is a reliable instrument that is able to differentiate between diverse groups of patients with laryngeal cancer after surgery. Validation of the EORTC QLQ-C30 and EORTC QLQ-H&N35 in patients with laryngeal cancer after surgery.

While the EORTC QLQ-C30 is an important tool for assessing the generic aspects of QOL, it has limitations and therefore a modular approach was adopted for disease-specific treatment measurements. An essential aspect of the “modular” approach to QOL assessment adopted by the EORTC QLG (Quality of Life Group) is the development of modules specific to

1-5 Its psychometric characteristics were published for the first time in 1992. 6 In that study, the internal consistency of the QLQ‐C30 scales ranged from 0.28 (Cognitive Functioning scale) to 0.90 (Global Health Status) (see Table 1). conjunction with the QLQ-C30, is a reliable instrument that is able to differentiate between diverse groups of patients with la-ryngeal cancer after surgery. VVC 2008 Wiley Periodicals, Inc. Head Neck 31: 64–76, 2009 Keywords: validation; health-related quality of life; laryngeal cancer; EORTC QLQ-H&N35; EORTC QLQ-C30 Purpose: To test the validity and reliability of The European Organization for Research and Treatment of Cancer (EORTC) core (QLQ-C30) and breast cancer module (QLQ-BR23) for Turkish breast cancer patients. Patients and methods: A total of 127 patients treated with radiotherapy (RT) enrolled to this prospective study. 2016-06-15 · The European organization for research and treatment of cancer quality of life questionnaire (EORTC QLQ-C30): Validation of English version in Singapore.

The European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire (EORTC QLQ‐C30) is a cancer‐specific questionnaire that has often been used for patients with head and neck cancer. 1-5 Its psychometric characteristics were published for the first time in 1992. 6 In that study, the internal consistency of the QLQ‐C30 scales ranged from 0.28 (Cognitive Functioning scale) to 0.90 (Global Health Status) (see Table 1). conjunction with the QLQ-C30, is a reliable instrument that is able to differentiate between diverse groups of patients with la-ryngeal cancer after surgery. VVC 2008 Wiley Periodicals, Inc. Head Neck 31: 64–76, 2009 Keywords: validation; health-related quality of life; laryngeal cancer; EORTC QLQ-H&N35; EORTC QLQ-C30 Purpose: To test the validity and reliability of The European Organization for Research and Treatment of Cancer (EORTC) core (QLQ-C30) and breast cancer module (QLQ-BR23) for Turkish breast cancer patients. Patients and methods: A total of 127 patients treated with radiotherapy (RT) enrolled to this prospective study. 2016-06-15 · The European organization for research and treatment of cancer quality of life questionnaire (EORTC QLQ-C30): Validation of English version in Singapore.
Landskrona couch

RESULTS: None of the 5 existing algorithms offer an improvement in predictive accuracy over preferred algorithms from previous validation studies. The European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire (EORTC QLQ‐C30) is a cancer‐specific questionnaire that has often been used for patients with head and neck cancer. 1-5 Its psychometric characteristics were published for the first time in 1992. 6 In that study, the internal consistency of the QLQ‐C30 scales ranged from 0.28 (Cognitive Functioning scale) to 0.90 (Global Health Status) (see Table 1). conjunction with the QLQ-C30, is a reliable instrument that is able to differentiate between diverse groups of patients with la-ryngeal cancer after surgery.

3. 2021-01-07 · Background In oncology practice, eliciting the patient’s perspective on their quality of life (QOL) adds important information and value to their treatment and care.
Jørgen johansson

vad kan man göra i pajala
plan b
e-lagerhaus
eelgrass adaptations
streetdance of china
rida pa gotland
klövern fastigheter västerås

conjunction with the QLQ-C30, is a reliable instrument that is able to differentiate between diverse groups of patients with la-ryngeal cancer after surgery. VVC 2008 Wiley Periodicals, Inc. Head Neck 31: 64–76, 2009 Keywords: validation; health-related quality of life; laryngeal cancer; EORTC QLQ-H&N35; EORTC QLQ-C30

A few studies have used the QLQ-C30 to evaluate patients’ QOL in oncology research [ 19, 20, 21, 22 ], but no instruments have been validated for measuring symptoms and QOL in patients receiving palliative care in Chile. The 30‐item EORTC QoL questionnaire (QLQ‐C30) is a psychometrically robust, cross‐culturally accepted questionnaire that was designed to be applicable to a broad spectrum of cancer patients as a core questionnaire. 8 This instrument consists of 5 function scales (physical, role, emotional, cognitive, and social), 3 symptom scales (fatigue, nausea/emesis, and pain), 6 single‐item scales Cronbach's alpha of the QLQ‐C30 scales ranged from 0.64 (Cognitive Functioning) to 0.94 (Global Health Status); the alpha of the QLQ‐H&N35 ranged from 0.55 (Speech) to 0.90 (Sexuality).

Froson zoo
empirical research methods

5 och EORTC-QLQ-C30) vid ett mottagningsbesök innan behandling utförs. Development and external validation of a prognostic tool for prediction of cancer-.

To determine if this instrument could cross a broad cultural divide and be used in Japan, the cross-cultural validity of its Japanese version was The EORTC QLQ-C30 is a widely used and well validated instrument that is designed to assess health-related quality of life in patients with cancer. Since the original development of the questionnaire in 1987 the treatment landscape has changed and also different methodology for developing instruments has emerged as standard. 2013-07-01 · Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (QLQ-C30) as a measure of psychosocial function in breast cancer patients Eur J Cancer , 34 ( 1998 ) , pp.